DaVita (NYSE:DVA) reported quarterly earnings results on February 02, 2026 that exceeded analyst expectations.
The Healthcare company reported earnings per share of $3.40, beating the consensus estimate of $3.21 by $0.19 per share. Revenue came in at $3.6B, beating the estimate of $3.5B.
DaVita's stock moved following the earnings release. The stock currently trades at $136.96 with a market capitalization of $8.5B.


